呼吸道感染。
Respiratory infections.
机构信息
Division of Pulmonary and Critical Care Medicine, New York Presbyterian/Weill Cornell Medical Center, New York, NY, USA.
Department of Pulmonology, Hospital Clinic, University of Barcelona, IDIBAPS, ICREA, CIBERES, Barcelona, Spain
出版信息
Eur Respir Rev. 2022 Oct 19;31(166). doi: 10.1183/16000617.0150-2022. Print 2022 Dec 31.
Abstract
摘要
相似文献
1
Respiratory infections.
Eur Respir Rev. 2022 Oct 19;31(166). doi: 10.1183/16000617.0150-2022. Print 2022 Dec 31.
2
[Respiratory infections--still an essential problem in health care].
Duodecim. 1992;108(20):1715-7.
3
Diagnosis and management of recurrent respiratory papillomatosis.
Pediatr Infect Dis J. 2014 Dec;33(12):1283-4. doi: 10.1097/INF.0000000000000551.
4
[Chemo-antibiotic therapy in pneumology].
G Ital Chemioter. 1990 Jan-Dec;37(1-3):1-37.
5
[Diagnosis and therapy of respiratory syncytial virus infection].
Harefuah. 1987 Dec 15;113(12):397-8.
6
[Respiratory infections caused by environmental mycobacteria].
Arch Bronconeumol. 2005 Apr;41(4):206-19. doi: 10.1016/s1579-2129(06)60432-1.
7
Guidelines for the diagnoses and treatment of adult lower respiratory tract infections: a true "European cooperative effort".
Eur Respir J. 2005 Dec;26(6):979-81. doi: 10.1183/09031936.05.00102105.
8
Coding Bias in Respiratory Tract Infections May Obscure Inappropriate Antibiotic Use.
J Gen Intern Med. 2019 Jun;34(6):806-808. doi: 10.1007/s11606-018-4823-x.
9
Vitamin E may worsen acute respiratory tract infections in the elderly.
J Fam Pract. 2002 Nov;51(11):925.
10
Concomitant bacterial pneumonia and empirical antibiotics in severe respiratory syncytial virus infection.
Pediatr Crit Care Med. 2011 Jan;12(1):119; author reply 119-20. doi: 10.1097/PCC.0b013e3181fe292f.
引用本文的文献
1
Epidemiological characteristics of acute viral and mycoplasma respiratory infections in Yongzhou, China: a retrospective descriptive study.
Front Public Health. 2025 Jul 17;13:1614985. doi: 10.3389/fpubh.2025.1614985. eCollection 2025.
2
Climatic factors driving influenza transmission in Sahelian area: A twelve-year retrospective study in Niger (2010-2021).
PLoS One. 2025 May 8;20(5):e0322288. doi: 10.1371/journal.pone.0322288. eCollection 2025.
3
Efficacy of regular gargling with a cetylpyridinium chloride plus zinc containing mouthwash can reduce upper respiratory symptoms.
PLoS One. 2025 Feb 26;20(2):e0316807. doi: 10.1371/journal.pone.0316807. eCollection 2025.
4
Key performance evaluation of commercialized multiplex rRT-PCR kits for respiratory viruses: implications for application and optimization.
Microbiol Spectr. 2024 Oct 29;12(12):e0164124. doi: 10.1128/spectrum.01641-24.
5
Epidemiological characteristics and meteorological factors of acute respiratory infections (ARIs) in hospitalized children in eastern Guangdong, China.
Sci Rep. 2024 Oct 26;14(1):25518. doi: 10.1038/s41598-024-77005-5.
6
Distribution characteristics of human herpes viruses in the lower respiratory tract and their impact on 30-day mortality in community-acquired pneumonia patients.
Front Cell Infect Microbiol. 2024 Aug 16;14:1436509. doi: 10.3389/fcimb.2024.1436509. eCollection 2024.
7
Anti-Inflammatory, Antibacterial, Anti-Biofilm, and Anti-Quorum Sensing Activities of the Diterpenes Isolated from .
Pharmaceutics. 2024 Aug 20;16(8):1094. doi: 10.3390/pharmaceutics16081094.
8
Aquaporin 1 aggravates lipopolysaccharide-induced macrophage polarization and pyroptosis.
Sci Rep. 2024 Aug 10;14(1):18569. doi: 10.1038/s41598-024-68899-2.
9
Evaluation of the FPMC respiratory panel for detection of respiratory tract pathogens in nasopharyngeal swab and sputum specimens.
Virol J. 2024 Jul 11;21(1):156. doi: 10.1186/s12985-024-02430-x.
10
Developing a model of public health system strengthening during pandemic of new emerging respiratory diseases for Iran: A protocol study.
J Educ Health Promot. 2024 Mar 28;13:117. doi: 10.4103/jehp.jehp_1320_23. eCollection 2024.
本文引用的文献
1
Severe community-acquired pneumonia.
Eur Respir Rev. 2022 Dec 14;31(166). doi: 10.1183/16000617.0123-2022. Print 2022 Dec 31.
2
Pulmonary aspergillosis: diagnosis and treatment.
Eur Respir Rev. 2022 Nov 29;31(166). doi: 10.1183/16000617.0114-2022. Print 2022 Dec 31.
3
Parasitic lung diseases.
Eur Respir Rev. 2022 Nov 29;31(166). doi: 10.1183/16000617.0093-2022. Print 2022 Dec 31.
4
The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic.
Eur Respir Rev. 2022 Oct 19;31(166). doi: 10.1183/16000617.0068-2022. Print 2022 Dec 31.
5
Respiratory viruses: their importance and lessons learned from COVID-19.
Eur Respir Rev. 2022 Oct 19;31(166). doi: 10.1183/16000617.0051-2022. Print 2022 Dec 31.
6
How and when to manage respiratory infections out of hospital.
Eur Respir Rev. 2022 Oct 19;31(166). doi: 10.1183/16000617.0092-2022. Print 2022 Dec 31.
7
Non- mould lung infections.
Eur Respir Rev. 2022 Oct 19;31(166). doi: 10.1183/16000617.0104-2022. Print 2022 Dec 31.
8
Management of complex and pulmonary disease: therapeutic advances and emerging treatments.
Eur Respir Rev. 2022 Feb 9;31(163). doi: 10.1183/16000617.0212-2021. Print 2022 Mar 31.
Zotero 插件